Ozempic, a drug used to treat type 2 diabetes and promote weight loss, has gained popularity in the pharmaceutical market due to its effectiveness in managing blood sugar levels. This trend reflects a growing emphasis on health and wellness among consumers.
GLP-1 drugs, which include Ozempic, have significant implications for various sectors within the US retail market, including grocery and apparel. Companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart are mentioned in this report, highlighting the potential impact on these businesses.
To access this exclusive report that explores the effects of widespread GLP-1 drug use on the retail industry, subscribers must log in. Subscribers can gain valuable insights into this topic by logging in. If you are not a subscriber yet and want to learn more about subscriptions and access to relevant research.